Bausch + Lomb Corporation

BLCO Healthcare Medical Instruments & Supplies

Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.

Revenue
+7.34%
EPS
+222.4%
Free cash flow
+182.5%
Total debt
+2.93%

Quarter to September 2026, against a year earlier

19.94 0.66 −3.20%
Market cap
$7.1B
P/E
0.0×
Fwd P/E
749×
Dividend yield
—
F-score
3/9
Altman Z
0.87
Beneish M
−2.52
Dividend safety
n/a

Bausch + Lomb Corporation (BLCO) Book value per share

Alert me on Book value per share

Bausch + Lomb Corporation's book value per share at the end of fiscal 2025 was 18.4×, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was 18.2×. Over the past ten years it has ranged from 18.4× (fiscal 2025) to 28.5× (fiscal 2020) — the current reading is the lowest in ten years. Bausch + Lomb Corporation ranks 19th of 52 Medical Instruments & Supplies companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 18.4× (0.95%)
FY2024 18.6× (5.78%)
FY2023 19.7× (2.69%)
FY2022 20.3× (24.47%)
FY2021 26.9× (5.87%)
FY2020 28.5× —

Quarterly newest first

Period Book value per share Change
Sep 2026 18.2× 0.88%
Jun 2026 18.0× (0.66%)
Mar 2026 18.2× (1.42%)
Dec 2025 18.4× 0.41%
20 more quarters

Against its own ten years

Low 18.4× High 28.5×
Ten-year median 20.0×
Current reading's percentile 17

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on BLCO